PubMedHealth treatment related to Decubitus Ulcer: 59
As much pressure as possible should be taken off of the pressure ulcer. The most important thing is to stop sitting or lying on the wound. Special positioning aids, special soft mattresses, and regular repositioning and movement help to relieve the pressure.Sterile wound dressings are usually used to protect the wound and help it to heal. If necessary, the wound is also regularly cleaned and dead tissue removed. The most appropriate treatment will depend on the type and severity of the pressure ulcer.
Drugs for Decubitus Ulcer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 205)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Nitric Oxide |
Approved |
Phase 4,Phase 1,Phase 2 |
|
10102-43-9 |
145068
|
Synonyms:
(.)NO
(NO)(.)
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
Monoxido de nitrogeno
monoxyde d'azote
Monoxyde d'azote
Nitrate Vasodilator, Endogenous
nitric oxide
|
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric Oxide, Endothelium Derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
NO(.)
OHM 11771
Oxide, Nitric
oxido de nitrogeno(II)
Oxido de nitrogeno(ii)
oxido nitrico
Oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(ii)-oxid
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
|
|
2 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337
|
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl Aminobenzoate
Ethyl aminobenzoate (JP15)
|
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-Aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-Aminophenylcarboxylate
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-B
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
p-Ethoxycarboxylic Aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim Mint Gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
3 |
|
Petrolatum |
Approved, Investigational |
Phase 4 |
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
4 |
|
Alginic acid |
Approved, Experimental, Investigational |
Phase 4,Phase 3 |
|
9005-32-7 |
|
Synonyms:
algin
alginate
Alginate
E400
Gum levan
|
Kelacid
Levan gum
Norgine
Sazio
|
|
5 |
|
Midazolam |
Approved, Illicit |
Phase 4,Phase 2,Phase 3 |
|
59467-70-8 |
4192
|
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
Dazolam
DB00683
Dea No. 2884
DEA No. 2884
Dormicum
|
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
midazolam
Midazolam
Midazolam (JAN/INN)
Midazolam [INN:BAN:JAN]
Midazolam Base
Midazolam Hcl
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
nchembio747-comp32
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
|
|
6 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290
|
Synonyms:
(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
143558-00-3
AC1L9AWM
BIDD:GT0360
C07556
CHEBI:8884
CID441290
|
DB00728
Esmeron
HMS2090E03
NCGC00167433-01
Rocuronium
Rocuronium bromide
Zemuron
|
|
7 |
|
Sevoflurane |
Approved, Vet_approved |
Phase 4,Phase 2 |
|
28523-86-6 |
5206
|
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
Bax 3084
BRN 2041023
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
|
MolPort-001-775-746
MR_6S4
MR6S4
NCGC00167421-01
PC4681
Sevofluran
sevoflurane
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
Ultane
Ultane (TN)
UNII-38LVP0K73A
ZINC01530810
|
|
8 |
|
Bupivacaine |
Approved, Investigational |
Phase 4,Phase 2,Phase 3 |
|
38396-39-3, 2180-92-9 |
2474
|
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(±)-bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
15233-43-9
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
2180-92-9
38396-39-3
AB00053674
AC1L1DRE
AC1Q5LX4
AC-2096
AH 250
AKOS001637202
Anekain
AR-1A0242
Bio-0886
Bloqueina
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
bupivacaine
Bupivacaine (INN)
Bupivacaine [INN:BAN]
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Monohydrochloride, Monohydrate
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
Carbostesin
cBupivacaine
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
D07552
DB00297
DepoBupivacaine
|
DivK1c_000758
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DUR-843
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MLS001361336
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SMR000058218
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
|
|
9 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943
|
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-di(propan-2-yl)phenol
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-DIISOPROPYLPHENOL
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
Abbott Brand of Propofol
AC1L1J9Y
AC1Q1OUI
AC-2038
AI3-26295
Alpha Brand of Propofol
AM-149
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
Biomol-NT_000248
BPBio1_000950
BPBio1_000969
Braun Brand of Propofol
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD000059151
CPD-11437
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
ghl.PD_Mitscher_leg0.558
HMS1570L04
HMS2089O21
HMS2094E17
|
HSDB 7123
ICI 35,868
ICI 35868
ICI35,868
ICI-35,868
ICI35868
ICI-35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
Lopac0_000437
Lopac-D126608
LS-996
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
nchembio.552-comp7
NSC 5105
NSC5105
Parnell Brand of Propofol
PFL
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
propofol
Propofol
Propofol (JAN/USAN/INN)
Propofol [USAN:INN:BAN]
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
Schering Brand of Propofol
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
Zeneca Brand of Propofol
ZINC00968303
|
|
10 |
|
Ropivacaine |
Approved |
Phase 4 |
|
84057-95-4 |
175805
71273
|
Synonyms:
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
L-N-n-propylpipecolic acid-2,6-xylidide
LS-113954
MLS001401363
|
MolPort-003-983-292
Naropin
Naropin (TN)
NCGC00164597-01
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
ROPIVACAINE HCl
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
SAM001246524
SMR000469137
S-Ropivacaine
ST51051452
|
|
11 |
|
Mepivacaine |
Approved, Vet_approved |
Phase 4 |
|
96-88-8 |
4062
|
Synonyms:
(+-)-1-Methyl-2',6'-pipecoloxylidide
1722-62-9 (mono-hydrochloride)
1-methyl-2',6'-pipecoloxylidide
1-METHYL-2',6'-PIPECOLOXYLIDIDE
22801-44-1
34811-66-0
5-22-01-00223 (Beilstein Handbook Reference)
96-88-8
AC-15503
AC1L1HBV
Arestocaine HCL
BRD-A03216249-003-02-9
BRN 0211230
BSPBio_003297
C07528
Carbocaine
Carboplyin Dental
Carboplyin Dental (TN)
CHEBI:6759
CHEMBL1087
CID4062
D(-)-Mepivacaine
D08181
DB00961
DivK1c_006970
DL-Mepivacaine
D-mepivacaine
EINECS 202-543-0
I01-1864
Isocaine HCL
KBio1_001914
KBio2_001960
KBio2_004528
KBio2_007096
KBio3_002517
|
KBioGR_001092
KBioSS_001960
LS-109848
LS-109849
Mepivacaina
Mepivacaina [INN-Spanish]
mepivacaine
Mepivacaine (INN)
Mepivacaine [INN:BAN]
Mepivacaine HCL
Mepivacaine hydrochloride
Mepivacainum
Mepivacainum [INN-Latin]
Mepivicaine
MolPort-005-935-383
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
NCGC00089774-02
N-Methyl-2-pipecolic acid, 2,6-dimethylanilide
N-Methyl-2-pipecolic acid, 2,6-xylidide
N-Methylhexahydro-2-picolinic acid, 2,6-dimethylanilide
Polocaine-Mpf
Scandicain
Scandicaine
Scandicane
SPBio_001811
SpecPlus_000874
Spectrum_001480
Spectrum2_001656
Spectrum3_001629
Spectrum4_000596
Spectrum5_001354
S-Ropivacaine Mesylate
UNII-B6E06QE59J
|
|
12 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4,Phase 2,Phase 3 |
|
437-38-7 |
3345
|
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-phenethyl-4-N-propionylanilinopiperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
fentanyl
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl [INN:BAN]
Fentanyl CII
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
|
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
Nasalfent
NCGC00168252-01
N-phenethyl-4-(N-propionylanilino)piperidine
N-Phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
|
|
13 |
|
Sufentanil |
Approved, Investigational |
Phase 4 |
|
56030-54-7 |
41693
|
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
Chronogesic
CID41693
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
|
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
Sufentanil
SUFENTANIL
Sufentanil (USAN/INN)
Sufentanil [USAN:BAN:INN]
Sufentanil Citrate
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
|
|
14 |
|
Prilocaine |
Approved |
Phase 4 |
|
721-50-6 |
4906
|
Synonyms:
2-(Propylamino)-o-propionotoluidide
2-(Propylamino)-O-propionotoluidide
2-Methyl-.alpha.-propylaminopropionanilide
2-Methyl-alpha-propylaminopropionanilide
721-50-6
AB00053665
AC1L1J7W
AC-2100
alpha-n-Propylamino-2-methylpropionanilide
alpha-N-Propylamino-2-methylpropionanilide
Ambap1786-81-8
Astra 1512
Astra 1515
BPBio1_000173
BRD-A53952395-003-05-3
BRN 2108498
BSPBio_000157
BSPBio_002604
C07531
C13H20N2O
CHEBI:8404
CHEMBL1194
CID4906
Citanest
D00553
DB00750
DivK1c_000846
EINECS 211-957-0
HSDB 3386
I01-1860
IDI1_000846
KBio1_000846
KBio2_002129
KBio2_004697
KBio2_007265
KBio3_001824
KBioGR_001883
KBioSS_002129
L 67
Lopac0_001005
LS-2304
|
MolPort-005-935-583
N-(2-Methylphenyl)-2-(propylamino)propanamide
N-(2-methylphenyl)-N(2)-propylalaninamide
N-(2-methylphenyl)-N2-propylalaninamide
N-[2-Methylphenyl]-2-[propylamino]propanamide
NCGC00015860-03
NCGC00162312-01
NINDS_000846
NSC 40027
NSC40027
o-Methyl-2-propylaminopropionanilide
O-Methyl-2-propylaminopropionanilide
o-Methyl-alpha-propylaminopropionanilide
O-Methyl-alpha-propylaminopropionanilide
Prestwick0_000199
Prestwick1_000199
Prestwick2_000199
Prestwick3_000199
Prilocain
Prilocaina
Prilocaina [INN-Spanish]
prilocaine
Prilocaïne
Prilocaine (USP/INN)
Prilocaine [USAN]
prilocaine base
Prilocaine base
Prilocainum
Prilocainum [INN-Latin]
Propanamide, N-(2-methylphenyl)-2-(propylamino)- (9CI)
Propitocaine
Propitocaine (JAN)
S1619_Selleck
SPBio_001398
SPBio_002078
Spectrum_001649
Spectrum2_001549
Spectrum3_001052
Spectrum4_001192
Spectrum5_001175
UNII-046O35D44R
|
|
15 |
|
Titanium dioxide |
Approved |
Phase 4 |
|
13463-67-7 |
|
16 |
|
Dopamine |
Approved |
Phase 4 |
|
51-61-6, 62-31-7 |
681
|
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
hydroxytyramine
|
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
17 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1 |
3821
|
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
100477-72-3
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
Calypsol
Cetamina
Cetamina [INN-Spanish]
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
|
DivK1c_000217
dl-Ketamine
DL-ketamine
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
Ketaject
Ketalar
Ketalar base
Ketamina
ketamine
Kétamine
Ketamine (INN)
Ketamine [INN:BAN]
Ketamine Base
Ketamine HCL
KETAMINE HCL
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
l-Ketamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
|
|
18 |
|
Magnesium Sulfate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
7487-88-9 |
24083
|
Synonyms:
(C10-C16) Alkylalcohol sulfuric acid, magnesium salt
00627_FLUKA
10028-26-9
10034-99-8 (heptahydrate)
13143_RIEDEL
13143_SIAL
139939-75-6
18939-43-0
203726_ALDRICH
208094_SIAL
34276_FLUKA
34276_RIEDEL
38146_FLUKA
38146_RIEDEL
63126_FLUKA
63136_FLUKA
63136_SIAL
63139_FLUKA
63139_SIAL
68081-97-0
7487-88-9
AC1L2N76
AC1LAX36
AC1Q1U66
AI3-02029
Bitter salt
C10-C16 Alkyl alcohol sulfuric acid magnesium salt
Caswell No. 534
CCRIS 8411
CHEBI:32599
CID24083
CPD0-2390
D008278
DB00653
EINECS 231-298-2
EINECS 233-073-4
EINECS 242-691-3
EINECS 268-365-0
EPA Pesticide Chemical Code 050503
Epsom salt
Hair salt
Heptahydrate Magnesium Sulfate
HSDB 664
Kieserite [as monohydrate]
LS-88605
M2643_SIGMA
M3409_SIGMA
M7506_SIAL
|
M8150_SIGMA
Magnesium bisulfate
Magnesium hydrogensulphate
Magnesium sulfate
MAGNESIUM SULFATE
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulfate dried
Magnesium sulfate heptahydrate
Magnesium sulfate hexahydrate
Magnesium sulfate in dextrose 5% in plastic container
Magnesium Sulfate In Plastic Container
Magnesium sulfate solution
Magnesium Sulfate, Heptahydrate
Magnesium sulphate
Magnesium sulphate anhydrous
Magnesium sulphate dried
Magnesium sulphate heptahydrate
Magnesium Sulphate Hydrate
magnesium(2+) ion sulfate
Magnesium(ii) sulfate
Magnesium(II) sulfate
Magnesiumsulfat
MgSO4
MolPort-003-925-000
NSC 146179
OT-S
OT-S (drying agent)
Sal amarum
Sal Angalis
Sal anglicum
Sal catharticum
Sal De sedlitz
Sal seidlitense
Salts of england
SDA 15-062-07
Sel d'angleterre
Sulfate, Magnesium
Sulfuric acid magnesium salt
Sulfuric acid magnesium salt (1:1)
Sulfuric acid magnesium salt (VAN)
Sulfuric acid, C10-16 alkyl ester, magnesium salt
Sulfuric acid, magnesium salt
Sulfuric acid, magnesium salt (1:1)
Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts
Tomix OT
UNII-DE08037SAB
UNII-ML30MJ2U7I
|
|
19 |
|
Thrombin |
Approved, Investigational |
Phase 4 |
|
|
|
Synonyms:
coagulation factor II
Thrombin bovine
|
Thrombin, Topical (Bovine)
|
|
20 |
|
acetic acid |
Approved, Nutraceutical |
Phase 4 |
|
64-19-7 |
176
|
Synonyms:
Acetate
Acetic acid, glacial
Aceticum acidum
acide acétique
Essigsäure
Ethanoat
Ethanoate
Ethanoic acid
Ethoic acid
Ethylate
|
Ethylic acid
Glacial acetate
Glacial acetic acid
HOAc
Kyselina octova
Methanecarboxylate
Methanecarboxylic acid
Vinegar
Vinegar acid
|
|
21 |
|
tannic acid |
Approved, Nutraceutical |
Phase 4 |
|
|
|
22 |
|
St. John's Wort |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
84082-80-4 |
|
Synonyms:
Common st johnswort flowering top
Common st. john's wort flowering top
Common st. john's wort herb
Common st. johnswort flowering top
Guanyejinsitao
Hyperici herba
Hypericum nachitschevanicum flowering top
Hypericum perforatum flowering top
|
Hypoxis hemerocallidea root extract
Klamath weed flowering top
Klamathweed flowering top
Saint johns wort
St john's wort
St Johns Wort
St. johns wort
St. johnswort flowering top
|
|
23 |
|
Vitamin C |
Approved, Nutraceutical |
Phase 4 |
|
50-81-7 |
54670067
5785
|
Synonyms:
(+)-ascorbate
(+)-ascorbic acid
(+)-Sodium L-ascorbate
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
30208-61-8
33034_RIEDEL
33034_SIAL
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
Acid Ascorbic
acide ascorbique
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
ácido ascórbico
Acido ascorbico [INN-Spanish]
acidum ascorbicum
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
acidum ascorbinicum
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
antiscorbic vita min
Antiscorbic vitamin
Antiscorbutic factor
Antiscorbutic vitamin
AR-1J3435
Arco-cee
Ascoltin
Ascoltin (TN)
Ascorb
ascor-b.i.d
Ascor-B.I.D.
Ascorbajen
ascorbate
Ascorbate
ascorbic acid
Ascorbic acid
Ascorbic Acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbic Acid, Monosodium Salt
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
bmse000182
BPBio1_000363
BSPBio_000329
C00072
C6H8O6
Cantan
Cantaxin
Caswell No. 061B
Catavin C
CCRIS 57
Ce lent
Cebicure
Cebid
Cebion
Cebione
Cecon
cee-caps td
Cee-caps TD
Cee-Caps TD
Cee-vite
Cee-Vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Ce-Mi-Lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-Caps TC
Cetane-caps TD
Cetane-Caps TD
Cetebe
Cetemican
Cevalin
Cevatine
|
Cevex
cevibid
Cevi-bid
Cevi-Bid
Cevimin
Ce-vi-sol
CE-VI-Sol
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
CHEBI:29073
CHEMBL196
Chewcee
Ciamin
CID5785
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
Concemin
Cortalex
C-Quin
C-Span
C-Vimin
D00018
Davitamon C
DB00126
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
Hicee
HiCee
HSDB 818
Hybrin
Ido-C
IDO-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L-(+)-Ascorbate
L-(+)-ascorbic acid
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-(+)-Ascorbic Acid
L-3-ketothreohexuronic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-ascorbate
L-Ascorbate
l-ascorbic acid
L-Ascorbic acid
L-Ascorbic Acid
L-Ascorbic acid, free radical form
Lemascorb
Liqui-cee
Liqui-Cee
L-Lyxoascorbate
L-Lyxoascorbic acid
LS-145
L-threo-ascorbic acid
L-Threoascorbic acid
L-Threo-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-hex-2-enono-1,4-lactone
L-Xyloascorbate
L-Xyloascorbic acid
Magnesium Ascorbicum
Magnorbin
Meri-c
Meri-C
MLS002153776
MolPort-001-792-501
Monodehydroascorbic acid
Natrascorb
Natrascorb injectable
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
NCI-C54808
NSC 33832
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
roscorbi c
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
SMR001233160
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
vitamin C
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
|
|
24 |
|
Bismuth |
|
Phase 4 |
|
7440-69-9 |
105143
16682734
|
Synonyms:
17034_FLUKA
24267-48-9
25243-76-9
264008_ALDRICH
265462_ALDRICH
265470_ALDRICH
452386_ALDRICH
556130_ALDRICH
7440-69-9
83Bi
95372_ALDRICH
95372_FLUKA
95375_FLUKA
AC1NSDYX
AC1O4PN8
AR-1I0647
Bi
Bismut
|
bismuth
Bismuth standard for AAS
Bismuth standard for ICP
Bismuth(III) nitrate solution
BISMUTH, 99.95%
BISMUTH, 99.999%
Bismuth, elemental
Bismuth-209
bismuto
C15471
CHEBI:33301
CID5359367
EINECS 231-177-4
HSDB 2078
LS-44708
LTBB002773
MolPort-003-925-759
Wismut
|
|
25 |
|
Retinol acetate |
|
Phase 4 |
|
127-47-9 |
10245972
|
Synonyms:
13-cis-Retinyl acetate
Acetateall-trans-Retinol
Acetic acid, retinyl ester
All-trans-retinol acetate
All-trans-retinyl acetate
All-trans-Retinyl acetate
All-trans-retinylacetate
All-trans-vitamin a acetate
Crystalets
Davitan A 650
Myvak (van)
Myvax (van)
O(15)-Acetylretinol
O~15~-Acetylretinol
O~15~-Acetyl-retinol
Retinol acetate
|
Retinol acetate (JP15)
RETINOL ACETATE (SEE RETINOIDPROJECTS 1 AND 3)
Retinol, acetate
Retinol, acetate, all-trans- (8CI)
Retinol, acetate, labeled with tritium
Retinyl acetate
Trans-retinyl acetate
Trans-vitamin a acetate
Vitamin A acetate
Vitamin a acetate (tritiated)
Vitamin a acetate (van)
Vitamin a alcohol acetate
Vitamin a ester
Vitamin a, acetate
Vitamin A1 acetate
|
|
26 |
|
Neurotransmitter Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1 |
|
|
|
27 |
|
Anesthetics |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
28 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
29 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1 |
|
|
|
30 |
|
Pharmaceutical Solutions |
|
Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 |
|
|
|
31 |
|
Protective Agents |
|
Phase 4,Phase 3,Phase 1,Phase 2 |
|
|
|
32 |
|
Analgesics |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
33 |
|
Cathartics |
|
Phase 4 |
|
|
|
34 |
|
Central Nervous System Depressants |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
35 |
|
Adjuvants, Anesthesia |
|
Phase 4,Phase 2 |
|
|
|
36 |
|
Narcotics |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
37 |
|
Sunscreening Agents |
|
Phase 4 |
|
|
|
38 |
|
Gastrointestinal Agents |
|
Phase 4,Phase 2 |
|
|
|
39 |
|
Analgesics, Opioid |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
40 |
|
Anesthetics, General |
|
Phase 4,Phase 2 |
|
|
|
41 |
|
Anesthetics, Intravenous |
|
Phase 4,Phase 2 |
|
|
|
42 |
|
Anesthetics, Local |
|
Phase 4,Phase 2,Phase 3 |
|
|
|
43 |
|
Photosensitizing Agents |
|
Phase 4 |
|
|
|
44 |
|
Laxatives |
|
Phase 4 |
|
|
|
45 |
|
Radiation-Protective Agents |
|
Phase 4,Phase 3 |
|
|
|
46 |
|
Carboxymethylcellulose Sodium |
|
Phase 4 |
|
|
|
47 |
|
Tissue Plasminogen Activator |
|
Phase 4 |
|
|
|
48 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
49 |
|
N 0437 |
|
Phase 4 |
|
|
|
50 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 410)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers |
Unknown status |
NCT02689310
|
Phase 4 |
|
2 |
Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care |
Unknown status |
NCT01595347
|
Phase 4 |
Hyper-oxigenated fatty acid |
3 |
Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. |
Unknown status |
NCT01734109
|
Phase 4 |
|
4 |
Clinical Evaluation of the SNaP Wound Care System |
Unknown status |
NCT01113658
|
Phase 4 |
|
5 |
Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury |
Unknown status |
NCT00201968
|
Phase 4 |
|
6 |
Negative Pressure Wound Therapy With the Engenexâ„¢-Pump and Bio-Domeâ„¢ Dressing, an Evaluation |
Unknown status |
NCT01107821
|
Phase 4 |
|
7 |
Pressure Ulcer Healing With Microcyn |
Completed |
NCT02001558
|
Phase 4 |
Microcyn |
8 |
Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease |
Completed |
NCT01555593
|
Phase 4 |
|
9 |
Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation |
Completed |
NCT02526862
|
Phase 4 |
|
10 |
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Between Prone and Left Lateral Decubitus |
Completed |
NCT01599351
|
Phase 4 |
|
11 |
Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients |
Completed |
NCT01356732
|
Phase 4 |
Sufentanil |
12 |
A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration |
Completed |
NCT01438541
|
Phase 4 |
|
13 |
Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers |
Completed |
NCT00521027
|
Phase 4 |
|
14 |
The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function |
Completed |
NCT01547416
|
Phase 4 |
epidural 250mL of 0.2% ropivacaine and 2 μg/mL of fentanyl, 5 mL/hr continuous infusion and 0.5 mL bolus dose;no epidural drug administered |
15 |
Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers |
Completed |
NCT01036438
|
Phase 4 |
|
16 |
Femoral Blockade and Low-dose Spinal Anesthesia in Outpatient Knee Arthroscopy |
Completed |
NCT02322372
|
Phase 4 |
Femoral blockade;Intrathecal anesthesia |
17 |
Spinal Anesthesia Versus Combined Sciatic-femoral Nerve Block for Outpatient Knee Arthroscopy |
Completed |
NCT02384915
|
Phase 4 |
prilocaine;mepivacaine |
18 |
Surgical Approach Affect on Post-operative Analgesic Requirement Following Laparoscopic Nephrectomy |
Completed |
NCT02622893
|
Phase 4 |
Transperitoneal laparoscopic nephrectomy;Retroperitoneal laparoscopic nephrectomy |
19 |
Mesoglycan, Vascular Reactivity and Metabolic Syndrome |
Completed |
NCT02254850
|
Phase 4 |
Mesoglycan;Mesoglycan;Placebo;Placebo |
20 |
Wound Management for Sacral Pressure Ulcers With Necrotic Tissue |
Recruiting |
NCT02224638
|
Phase 4 |
|
21 |
Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst |
Recruiting |
NCT02485860
|
Phase 4 |
|
22 |
TAVI Protocol - Paravertebral Block Study |
Recruiting |
NCT01404975
|
Phase 4 |
|
23 |
Fibrinolytic Therapy Versus Medical Thoracoscopy |
Recruiting |
NCT03213834
|
Phase 4 |
tPA;DNase |
24 |
Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors |
Active, not recruiting |
NCT03098368
|
Phase 4 |
Rotigotine;Placebo |
25 |
Ketamine and Refractory Painful Care in a Palliative Unit |
Not yet recruiting |
NCT02587130
|
Phase 4 |
Ketamine |
26 |
Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics. |
Not yet recruiting |
NCT03322878
|
Phase 4 |
Magnesium SO4 |
27 |
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers |
Terminated |
NCT02718625
|
Phase 4 |
|
28 |
Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds |
Terminated |
NCT00691821
|
Phase 4 |
|
29 |
Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip |
Terminated |
NCT01593319
|
Phase 4 |
Ropivacaine;Natrium chloride |
30 |
Manuka Honey for Wound Care |
Terminated |
NCT02259491
|
Phase 4 |
Manuka Honey Dressing |
31 |
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers |
Withdrawn |
NCT02248077
|
Phase 4 |
|
32 |
Use of Santyl Within an Accountable Care Organization |
Withdrawn |
NCT02716519
|
Phase 4 |
|
33 |
PEMF Effects on Pain After Abdominal Body Contouring |
Withdrawn |
NCT01762423
|
Phase 4 |
|
34 |
A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites |
Withdrawn |
NCT02994589
|
Phase 4 |
|
35 |
Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions |
Unknown status |
NCT02711839
|
Phase 2, Phase 3 |
|
36 |
Clinical Value of Noninvasive Intracranial Pressure Measurement |
Unknown status |
NCT02130219
|
Phase 2, Phase 3 |
|
37 |
Pressure Ulcer Prevention: Turning for Ulcer Reduction |
Completed |
NCT00665535
|
Phase 3 |
|
38 |
Pressure Ulcer Prevention Study in SCI |
Completed |
NCT01999816
|
Phase 3 |
|
39 |
Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens |
Completed |
NCT00847665
|
Phase 3 |
|
40 |
Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers |
Completed |
NCT01008254
|
Phase 2, Phase 3 |
|
41 |
Informativeness to Digital Rectal Examination |
Completed |
NCT01727388
|
Phase 3 |
|
42 |
Pressure Ulcer Multi-disciplinary Teams Via Telemedicine (PUMTT): A Trial in Long Term Care |
Completed |
NCT01232764
|
Phase 3 |
|
43 |
Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study |
Completed |
NCT00796042
|
Phase 3 |
|
44 |
Efficacy of Prontosan Solution on Chronic Ulcers |
Completed |
NCT01333670
|
Phase 3 |
Isotonic solution (saline or lactated ringer) |
45 |
Maggot Therapy for Wound Debridement |
Completed |
NCT01211236
|
Phase 3 |
|
46 |
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing |
Completed |
NCT01214811
|
Phase 3 |
|
47 |
Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions |
Completed |
NCT01573234
|
Phase 3 |
|
48 |
Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs |
Completed |
NCT01532882
|
Phase 3 |
Diosmin;Placebo |
49 |
Botulinum Toxin Injections by Ultrasounds Guidance and Stretching Exercise in Spastic Toe Clawing |
Completed |
NCT02586142
|
Phase 3 |
Botulinum Toxin Type A |
50 |
Nutritional Therapy for Stroke Patients |
Completed |
NCT00163007
|
Phase 2, Phase 3 |
|
Cochrane evidence based reviews: pressure ulcer
|